SlideShare a Scribd company logo
1 of 8
RxNorm By  Mutahara Mobashar
Brief History In 2001, National Library of Medicine (NLM) began experimenting in modeling drugs in the Unified Medical Language System. The area clinical drugs was seen important in the growing issue of patient safety. Aim was to develop improved interoperability of drug terminology. RxNorm is a standardized nomenclature for clinical drugs produced by the NLM.  The RxNorm project approached clinical representation in a number of steps.
Brief History  The initial effort was to define Semantic Normal Form (SNF) to represent clinical drugs. SNF’s are canonical representations as defined by their strengths, active ingredients and orderable dosage form. There are two SNF’s created for every clinical drug: http://www.nlm.nih.gov/research/umls/rxnorm/history.html UMLS Basics: http://www.nlm.nih.gov/research/umls/online_learning/glossary.htm
Purpose of Vocabulary The need of a standardized nomenclature for a smooth exchange of information. The goal is to allow various systems, using different terms to be able to share information effectively.
RxNorm: Uses and applications RxNorm contains the names of prescriptions and many nonprescription formulations that exist in the US. Over the counter drugs will be added when reliable information about the medicine can be found. Medications with more than three ingredients are not represented at this time. RxNorm is organized by concept: http://www.nlm.nih.gov/research/umls/rxnorm/overview.html
RxNorm Uses and applications:  1. RxNav http://mor.nlm.nih.gov/download/rxnav/ 2. MyMedication List http://mml.nlm.nih.gov/ 3. RxTerms https://wwwcf.nlm.nih.gov/umlslicense/rxtermApp/rxTerm.cfm
users Researchers, doctors, pharmacists and all health professionals. Pretty much anyone can use some features that are applicable to them.
Questions?

More Related Content

Viewers also liked (9)

Welcome To 2010 Math
Welcome To 2010  MathWelcome To 2010  Math
Welcome To 2010 Math
 
UMSL State the the University Address September 2013
UMSL State the the University Address September 2013UMSL State the the University Address September 2013
UMSL State the the University Address September 2013
 
Deans Welcome Address
Deans Welcome AddressDeans Welcome Address
Deans Welcome Address
 
Opening remarks for nstp lts graduation 2012
Opening remarks for nstp lts graduation 2012Opening remarks for nstp lts graduation 2012
Opening remarks for nstp lts graduation 2012
 
Speeches
SpeechesSpeeches
Speeches
 
welcome speech
welcome speechwelcome speech
welcome speech
 
Welcome speech 2014
Welcome speech 2014Welcome speech 2014
Welcome speech 2014
 
Template Script for Emcees
Template Script for EmceesTemplate Script for Emcees
Template Script for Emcees
 
emcee / mc Opening speech example
emcee / mc Opening speech example emcee / mc Opening speech example
emcee / mc Opening speech example
 

Similar to Rx Norm

A Knowledge Graph-based Approach for Exploring the U.S. Opioid Epidemic
A Knowledge Graph-based Approach for Exploring the U.S. Opioid EpidemicA Knowledge Graph-based Approach for Exploring the U.S. Opioid Epidemic
A Knowledge Graph-based Approach for Exploring the U.S. Opioid Epidemic
Shea K. Zhao
 
Information Retrieval UMLS
Information Retrieval UMLSInformation Retrieval UMLS
Information Retrieval UMLS
siddarajuss
 
CV (J Roush)01Dec2014
CV (J Roush)01Dec2014CV (J Roush)01Dec2014
CV (J Roush)01Dec2014
John Roush
 
Assessing Drug Safety Using AI
Assessing Drug Safety Using AIAssessing Drug Safety Using AI
Assessing Drug Safety Using AI
Databricks
 
Rhenovia_Optivia partnership 19may15
Rhenovia_Optivia partnership 19may15Rhenovia_Optivia partnership 19may15
Rhenovia_Optivia partnership 19may15
sergebischoff1
 
Controlled vocabularies and VIVO
Controlled vocabularies and VIVOControlled vocabularies and VIVO
Controlled vocabularies and VIVO
Paul Albert
 
Pluripotent stem cells An in vitro model for nanotoxicity
Pluripotent stem cells An in vitro model for nanotoxicityPluripotent stem cells An in vitro model for nanotoxicity
Pluripotent stem cells An in vitro model for nanotoxicity
Dr. Harish Handral
 

Similar to Rx Norm (20)

A Knowledge Graph-based Approach for Exploring the U.S. Opioid Epidemic
A Knowledge Graph-based Approach for Exploring the U.S. Opioid EpidemicA Knowledge Graph-based Approach for Exploring the U.S. Opioid Epidemic
A Knowledge Graph-based Approach for Exploring the U.S. Opioid Epidemic
 
Information Retrieval UMLS
Information Retrieval UMLSInformation Retrieval UMLS
Information Retrieval UMLS
 
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
Linde Gas whitepaper 'Drug discovery advances inextricably linked to specialt...
 
CV (J Roush)01Dec2014
CV (J Roush)01Dec2014CV (J Roush)01Dec2014
CV (J Roush)01Dec2014
 
BioCreative2023_proceedings_instructions_authors_template.pdf
BioCreative2023_proceedings_instructions_authors_template.pdfBioCreative2023_proceedings_instructions_authors_template.pdf
BioCreative2023_proceedings_instructions_authors_template.pdf
 
Assessing Drug Safety Using AI
Assessing Drug Safety Using AIAssessing Drug Safety Using AI
Assessing Drug Safety Using AI
 
Nanotechnology in drug delivery
Nanotechnology in drug deliveryNanotechnology in drug delivery
Nanotechnology in drug delivery
 
Nanoparticulate drug delivery system : recent advances
Nanoparticulate drug delivery system : recent advancesNanoparticulate drug delivery system : recent advances
Nanoparticulate drug delivery system : recent advances
 
Protein6
Protein6Protein6
Protein6
 
121129 umls yes
121129 umls yes121129 umls yes
121129 umls yes
 
Presentation on Nanoparticles Smart Drug Delivery System For Cancer
Presentation on Nanoparticles Smart Drug Delivery System For Cancer Presentation on Nanoparticles Smart Drug Delivery System For Cancer
Presentation on Nanoparticles Smart Drug Delivery System For Cancer
 
Rhenovia_Optivia partnership 19may15
Rhenovia_Optivia partnership 19may15Rhenovia_Optivia partnership 19may15
Rhenovia_Optivia partnership 19may15
 
Controlled vocabularies and VIVO
Controlled vocabularies and VIVOControlled vocabularies and VIVO
Controlled vocabularies and VIVO
 
Information extraction from EHR
Information extraction from EHRInformation extraction from EHR
Information extraction from EHR
 
Controlled vocabularies for medical and health research
Controlled vocabularies for medical and health researchControlled vocabularies for medical and health research
Controlled vocabularies for medical and health research
 
Pluripotent stem cells An in vitro model for nanotoxicity
Pluripotent stem cells An in vitro model for nanotoxicityPluripotent stem cells An in vitro model for nanotoxicity
Pluripotent stem cells An in vitro model for nanotoxicity
 
microrna en sepsis 2016.pdf
microrna en sepsis 2016.pdfmicrorna en sepsis 2016.pdf
microrna en sepsis 2016.pdf
 
Implementation of a CEN/ISO 13606 Platform for Medicines Reconciliation
Implementation of a CEN/ISO 13606 Platform for Medicines ReconciliationImplementation of a CEN/ISO 13606 Platform for Medicines Reconciliation
Implementation of a CEN/ISO 13606 Platform for Medicines Reconciliation
 
MURI Summer
MURI SummerMURI Summer
MURI Summer
 
Role of bioinformatics of drug designing
Role of bioinformatics of drug designingRole of bioinformatics of drug designing
Role of bioinformatics of drug designing
 

Rx Norm

  • 1. RxNorm By Mutahara Mobashar
  • 2. Brief History In 2001, National Library of Medicine (NLM) began experimenting in modeling drugs in the Unified Medical Language System. The area clinical drugs was seen important in the growing issue of patient safety. Aim was to develop improved interoperability of drug terminology. RxNorm is a standardized nomenclature for clinical drugs produced by the NLM. The RxNorm project approached clinical representation in a number of steps.
  • 3. Brief History The initial effort was to define Semantic Normal Form (SNF) to represent clinical drugs. SNF’s are canonical representations as defined by their strengths, active ingredients and orderable dosage form. There are two SNF’s created for every clinical drug: http://www.nlm.nih.gov/research/umls/rxnorm/history.html UMLS Basics: http://www.nlm.nih.gov/research/umls/online_learning/glossary.htm
  • 4. Purpose of Vocabulary The need of a standardized nomenclature for a smooth exchange of information. The goal is to allow various systems, using different terms to be able to share information effectively.
  • 5. RxNorm: Uses and applications RxNorm contains the names of prescriptions and many nonprescription formulations that exist in the US. Over the counter drugs will be added when reliable information about the medicine can be found. Medications with more than three ingredients are not represented at this time. RxNorm is organized by concept: http://www.nlm.nih.gov/research/umls/rxnorm/overview.html
  • 6. RxNorm Uses and applications: 1. RxNav http://mor.nlm.nih.gov/download/rxnav/ 2. MyMedication List http://mml.nlm.nih.gov/ 3. RxTerms https://wwwcf.nlm.nih.gov/umlslicense/rxtermApp/rxTerm.cfm
  • 7. users Researchers, doctors, pharmacists and all health professionals. Pretty much anyone can use some features that are applicable to them.